missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Ozuriftamab Recombinant Monoclonal Antibody
GREENER_CHOICE

Recombinant Monoclonal Antibody

£397.00 - £1002.00

Specifications

Antigen Ozuriftamab Humanized
Concentration 1 mg/mL
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Applications ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
Classification Recombinant Monoclonal
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
30283580
GREENER_CHOICE
View Documents
Invitrogen™
MA560071
100 μg
£397.00
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
30282944
View Documents
Invitrogen™
MA560072
1 mg
£1002.00
1mg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.

Ozuriftamab is a biosimilar targeting the receptor tyrosine kinase orphan receptor 2 (ROR2). The ROR2 gene encodes the protein receptor tyrosine kinase-like orphan receptor 2 (ROR2), which is involved in non-canonical Wnt signaling pathways. ROR2 is known to play critical roles in skeletal development, particularly in the formation of limb bones and cartilage. The gene is located on chromosome 9 and consists of 9 exons that encode a protein of 943 amino acids with a single-pass transmembrane receptor structure. ROR2's extracellular region contains an immunoglobulin-like domain, a cysteine-rich domain (CRD), and a kringle domain, which facilitate its interaction with Wnt ligands such as Wnt5a and Wnt11. Upon ligand binding, ROR2 can homodimerize to initiate downstream signaling cascades that influence cell polarity, migration, and differentiation. Aberrations in ROR2 expression and function are implicated in various disorders, including Robinow syndrome and recessive renal cancer. Additionally, ROR2 has been noted to play a role in cancer cell motility and invasion, highlighting its potential as a therapeutic target.
Specifications

Specifications

Ozuriftamab Humanized
-20°C, Avoid Freeze/Thaw Cycles
Recombinant Monoclonal
Lyophilized
IgG1
Human
Primary
Protein A
1 mg/mL
ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance
Unconjugated
Human
RUO
25 mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2
Antibody
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.